Who is attending

Oxford Symposia - 5th Annual

OLIGO 2019 OXFORD:

Antisense & Therapeutic Nucleic Acids

1-2 April 2019, St Edmund Hall, Oxford, UK

Twitter: @LPMHealthcare, #OligoOx19

Who is attending

The following organisations are being represented at the symposium to-date. If you would like to get in touch with representative of an particular organisation before or during the conference, please let us know by email at Oligomer@lpmhealthcare.com.

  • Amorepacific R&D Center, South Korea
  • ATDBio Ltd, United Kingdom
  • Bambino Gesù Children’s Hospital (IRCCS), Italy
  • Carbosynth, United Kingdom
  • CNRS, France
  • Eli Lilly & Co, United Kingdom
  • Evox Therapeutics, United Kingdom
  • Friedrich Miescher Institute for Biomedical Research, Switzerland
  • Hebei Junzhi Medical Technology Company, China
  • HGF Limited, United Kingdom
  • Imperial College London, United Kingdom
  • Institut Pasteur, France
  • JP BIO A, South Korea
  • Karolinska Institutet, Sweden
  • King’s College London, United Kingdom
  • MRC Laboratory of Molecular Biology (Cambridge), United Kingdom
  • MiNA Therapeutics, United Kingdom
  • Pepgen Ltd, United Kingdom
  • Pharmaron, UK
  • Sirnaomics Inc, USA
  • SomaLogic Inc, USA
  • UCL Institute of Ophthalmology, United Kingdom
  • Universidade do Porto, Portugal
  • University College London, United Kingdom
  • University of Greenwich, United Kingdom
  • University of Hong Kong, China
  • University of Manchester, United Kingdom
  • University of Oxford, United Kingdom
  • University of Southern Denmark, Denmark
Countries/regions
  • China
  • Denmark
  • France
  • Italy
  • South Korea
  • Sweden
  • Switzerland
  • United Kingdom
  • USA